Clinical chemistry and laboratory medicine最新文献

筛选
英文 中文
Pre-analytical and analytical validation of calcitonin measurement in fine needle aspiration cytology washout. 细针抽吸细胞学冲洗中降钙素测定的分析前和分析验证。
IF 4.4 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2026-09-11 DOI: 10.1515/cclm-2026-1057
Amber Mater, Annemieke C Heijboer, Anita Boelen, Pim de Graaf, Koen M A Dreijerink, Jacquelien J Hillebrand
{"title":"Pre-analytical and analytical validation of calcitonin measurement in fine needle aspiration cytology washout.","authors":"Amber Mater, Annemieke C Heijboer, Anita Boelen, Pim de Graaf, Koen M A Dreijerink, Jacquelien J Hillebrand","doi":"10.1515/cclm-2026-1057","DOIUrl":"https://doi.org/10.1515/cclm-2026-1057","url":null,"abstract":"<p><strong>Objectives: </strong>Current guidelines advise calcitonin measurements in washout from fine needle aspiration cytology (FNAC) upon inconclusive cytological examination of medullary thyroid cancer (MTC). (Pre-)analytical validation studies of calcitonin measurements in FNAC washout are however missing. In this study, we examined (pre-)analytical aspects of calcitonin measurements using three washout solvents, aiming to provide insights for implementation of calcitonin measurements in FNAC washout as a supplementary test for diagnosing and monitoring patients with MTC.</p><p><strong>Methods: </strong>Validation studies were performed using CytoLyt, NaCl and MultiDiluent as washout solvents. Precision (intra- and inter-assay coefficients of variation (CV)), accuracy (linearity and recovery) and storage stability of each solvent were assessed after spiking with calcitonin standard. Calcitonin measurements were performed using the serum CALCT immunoassay (Siemens, Atellica). Decision criteria were set based on CLSI and manufacturer's manual.</p><p><strong>Results: </strong>Measurements of calcitonin in MultiDiluent met all decision criteria: intra- and inter-assay CVs were ≤5.5 % and ≤9 %, serial dilutions were linear (R<sup>2</sup>=0.997) and median recovery was 148 % with limited variation. Furthermore, calcitonin concentrations remained stable (<10 % change) after storage. Measurements in CytoLyt were precise and accurate, but unstable upon storage. Measurements in NaCl only met the criteria for intra-assay CV and linearity.</p><p><strong>Conclusions: </strong>This study showed that MultiDiluent was the optimal solvent to use for calcitonin measurements in a non-serum matrix using the Atellica calcitonin immunoassay. CytoLyt performed suboptimal, while the performance of NaCl was poor. Further research is needed to validate the recommended work-up using patient-derived material.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148918830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stoichiometric calibration of ceruloplasmin activity with copper enables molar quantification and has implications for the estimation of non-ceruloplasmin-bound copper. 铜蓝蛋白活性的化学计量校准使摩尔定量和非铜蓝蛋白结合铜的估计具有意义。
IF 4.4 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2026-09-11 DOI: 10.1515/cclm-2026-0510
Alexandra M Kane, Kurt T K Giuliani, Melanie Coogan, Linda Sanders, Richard G Ruddell, Matthew Burke, Carel J Pretorius, Jacobus P J Ungerer
{"title":"Stoichiometric calibration of ceruloplasmin activity with copper enables molar quantification and has implications for the estimation of non-ceruloplasmin-bound copper.","authors":"Alexandra M Kane, Kurt T K Giuliani, Melanie Coogan, Linda Sanders, Richard G Ruddell, Matthew Burke, Carel J Pretorius, Jacobus P J Ungerer","doi":"10.1515/cclm-2026-0510","DOIUrl":"https://doi.org/10.1515/cclm-2026-0510","url":null,"abstract":"<p><strong>Objectives: </strong>Ceruloplasmin (Cp) and non-ceruloplasmin-bound copper (NCC) are measured when evaluating liver disease and disorders of copper (Cu) metabolism. Cp mass concentration is typically determined by immunoassays that detect both apo- and holoceruloplasmin. In contrast, enzymatic assays measure Cp ferroxidase activity and are therefore specific for holoceruloplasmin. Their clinical use has been limited by the absence of a method to convert enzyme activity to molar Cp concentration and to estimate NCC.</p><p><strong>Methods: </strong>Cp ferroxidase activity and serum Cu concentrations were measured in a training dataset (n=924) to define their linear relationship and derive a conversion factor based on the stoichiometry of six Cu atoms per Cp molecule. This factor was applied to an independent validation cohort (n=12,635). Cp activity, Cp mass concentration, and serum Cu were compared, and reference intervals for Cp activity and NCC were established.</p><p><strong>Results: </strong>The calibration of Cp activity assay against Cu concentration yielded a conversion factor of 0.0030 for expressing Cp activity in molar units. Reference intervals for Cp activity were 1.5-3.7 μmol/L in males and 1.6-4.3 μmol/L in females. Comparison with nephelometric Cp measurements demonstrated a positive bias and evidence of analytical interference in a subset of samples.</p><p><strong>Conclusions: </strong>We describe a method to convert Cp ferroxidase activity to molar concentration and demonstrate its application in a large clinical cohort. This approach enables estimation of NCC, although with considerable uncertainty, and establishment of reference intervals using activity-based measurements. Measurement of Cp by enzymatic activity provides a cost-effective and analytically robust alternative to immunoassays, with advantages in specificity.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148929098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formula-dependent LDL-C threshold classification and reporting uncertainty in the UK Biobank. 英国生物银行中依赖公式的LDL-C阈值分类和报告的不确定性。
IF 4.4 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2026-09-11 DOI: 10.1515/cclm-2026-0687
Bohao Xue, Teng Ma, Cheng Shen, Xin Pan, Yichen Ling, Liangyu Chu, Wenting Yan, Ningjian Wang, Jin Li, Dachun Xu
{"title":"Formula-dependent LDL-C threshold classification and reporting uncertainty in the UK Biobank.","authors":"Bohao Xue, Teng Ma, Cheng Shen, Xin Pan, Yichen Ling, Liangyu Chu, Wenting Yan, Ningjian Wang, Jin Li, Dachun Xu","doi":"10.1515/cclm-2026-0687","DOIUrl":"https://doi.org/10.1515/cclm-2026-0687","url":null,"abstract":"<p><strong>Objectives: </strong>Calculated low-density lipoprotein cholesterol (LDL-C) is widely reported, but formula-dependent estimation differences may alter classification near decision thresholds. We assessed formula-dependent LDL-C classification relative to direct LDL-C in UK Biobank and examined cardiovascular outcomes descriptively.</p><p><strong>Methods: </strong>We analyzed 397,490 participants after quality-control exclusions and exclusion of those with missing direct LDL-C or triglycerides ≥4.52 mmol/L (≥400 mg/dL). Friedewald, Sampson-NIH, and Martin-Hopkins estimates were compared with the UK Biobank direct LDL-C comparator at a 2.60 mmol/L (100 mg/dL) method-comparison threshold. Analyses assessed threshold discordance, triglyceride strata, apolipoprotein B (apoB)/non-high-density lipoprotein cholesterol (non-HDL-C) phenotypes, threshold-window sensitivity analyses, and narrower atherosclerotic cardiovascular disease (ASCVD) endpoints.</p><p><strong>Results: </strong>Total threshold discordance was 5.96 % for Friedewald, 3.91 % for Sampson-NIH, and 3.23 % for Martin-Hopkins. Discordance increased with triglycerides. At 2.26-4.51 mmol/L (200-399 mg/dL), Friedewald had the largest negative calculated-minus-comparator difference and discordant low frequency (median difference -0.379 mmol/L; 12.9 %), whereas Martin-Hopkins had smaller differences (median -0.119 mmol/L; 4.3 %). Broad cardiovascular composite and narrower ASCVD endpoint models did not support binary threshold discordance as a stable adverse prognostic marker. Discordant low participants had higher triglycerides, body mass index (BMI), diabetes prevalence, and cholesterol-lowering medication use, but lower apoB and non-HDL-C.</p><p><strong>Conclusions: </strong>LDL-C formula selection affected classification, especially in triglyceride-rich samples near 2.60 mmol/L (100 mg/dL). Calculated LDL-C may warrant interpretation as an estimate with formula-related uncertainty near decision thresholds; non-HDL-C and, where available, apoB may provide complementary information.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148929177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DIN SPEC 91532: a process-oriented framework for quality assurance in clinical mass spectrometry. DIN SPEC 91532:临床质谱质量保证的过程导向框架。
IF 4.4 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2026-09-10 DOI: 10.1515/cclm-2026-0882
Michael Vogeser, Katharina M Rentsch, Peter Findeisen, Katharina Habler
{"title":"DIN SPEC 91532: a process-oriented framework for quality assurance in clinical mass spectrometry.","authors":"Michael Vogeser, Katharina M Rentsch, Peter Findeisen, Katharina Habler","doi":"10.1515/cclm-2026-0882","DOIUrl":"https://doi.org/10.1515/cclm-2026-0882","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148911052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac troponin in pediatric cardiology: toward standardized interpretive frameworks and clinical decision limits. 心脏肌钙蛋白在儿科心脏病学:标准化的解释框架和临床决策限制。
IF 4.4 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2026-09-10 DOI: 10.1515/cclm-2026-1248
Aldo Clerico, Martina Zaninotto, Mario Plebani
{"title":"Cardiac troponin in pediatric cardiology: toward standardized interpretive frameworks and clinical decision limits.","authors":"Aldo Clerico, Martina Zaninotto, Mario Plebani","doi":"10.1515/cclm-2026-1248","DOIUrl":"https://doi.org/10.1515/cclm-2026-1248","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148911065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative evaluation of p-tau217 stability in serum and plasma using two validated assays. 使用两种有效的测定方法对血清和血浆中p-tau217的稳定性进行比较评价。
IF 4.4 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2026-09-10 DOI: 10.1515/cclm-2026-1243
Arthur Guthknecht, Petra Steinacker, Samir Abu-Rumeileh, Markus Otto
{"title":"A comparative evaluation of p-tau217 stability in serum and plasma using two validated assays.","authors":"Arthur Guthknecht, Petra Steinacker, Samir Abu-Rumeileh, Markus Otto","doi":"10.1515/cclm-2026-1243","DOIUrl":"https://doi.org/10.1515/cclm-2026-1243","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148911060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating the futures of laboratory medicine. 引领实验室医学的未来。
IF 4.4 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2026-09-09 DOI: 10.1515/cclm-2026-1468
Mario Plebani, Elvar Theodorsson
{"title":"Navigating the futures of laboratory medicine.","authors":"Mario Plebani, Elvar Theodorsson","doi":"10.1515/cclm-2026-1468","DOIUrl":"https://doi.org/10.1515/cclm-2026-1468","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148905182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of point of care testing in time to treatment decision-making in emergency departments: a systematic review. 及时护理点检测对急诊科治疗决策的影响:系统综述
IF 4.4 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2026-09-09 DOI: 10.1515/cclm-2026-0604
Valentina Pecoraro, Giuseppe Banfi, Tommaso Trenti, Tommaso Fasano
{"title":"Impact of point of care testing in time to treatment decision-making in emergency departments: a systematic review.","authors":"Valentina Pecoraro, Giuseppe Banfi, Tommaso Trenti, Tommaso Fasano","doi":"10.1515/cclm-2026-0604","DOIUrl":"https://doi.org/10.1515/cclm-2026-0604","url":null,"abstract":"<p><p>The main characteristic of point-of-care testing (PoCT) is to provide rapid test results. It remains uncertain whether faster PoCT results truly improve patient management in the emergency department (ED), and how robust the supporting evidence is. This systematic review aimed to summarize the impact of PoCT in ED on time to clinical decision-making and major clinical outcomes (ED LOS, TAT, mortality, hospitalization, discharge, readmission or antibiotic administration). We searched PubMed, Embase and CENTRAL to identify studies evaluating PoCT in ED. The primary outcomes were the time to decision making and reduction in ED length of stay (LOS). We included 55 studies (approximately 142,000 subjects) evaluating molecular test for virus (n=19) or bacteria (n=2) detection, gastrointestinal infection (n=1), biochemical panel (n=12), troponin (n=9), C-reactive protein (n=2), lactate (n=3), human chorionic gonadotropin (HCG, n=2), d-dimer (n=1), monocyte distribution width (MDW, n=1), blood culture (n=1) and urinary tract infection (n=1) tests. Overall, the use PoCT reduced time to decision-making (ranged from -73 min to -96 min) and ED-LOS (MD -29.24 min 95 % CI from -46.11 to -12.38 min) compared to central laboratory testing. No significant differences were observed for major clinical outcomes. Although substantial statistical heterogeneity was identified, PoCT appears to guide faster clinical decision-making without any detrimental effects on clinical outcomes compared to standard laboratory testing. Future research should better define context dependent applications of PoCT translating faster results into meaningful changes in patient pathways and healthcare processes.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148911090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to "Quantifying M proteins: an analytical challenge beyond interference". 对“定量M蛋白:超越干扰的分析挑战”的回应。
IF 4.4 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2026-09-09 DOI: 10.1515/cclm-2026-1419
Shanshan Liang, Wei Gan
{"title":"Response to \"Quantifying M proteins: an analytical challenge beyond interference\".","authors":"Shanshan Liang, Wei Gan","doi":"10.1515/cclm-2026-1419","DOIUrl":"https://doi.org/10.1515/cclm-2026-1419","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148905143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AWMF Position Statement on the Revision of the EU's New Legislative Framework regarding the accreditation of medical laboratories. AWMF关于修订欧盟关于医学实验室认证的新立法框架的立场声明。
IF 4.4 2区 医学
Clinical chemistry and laboratory medicine Pub Date : 2026-09-09 DOI: 10.1515/cclm-2026-0986
Michael Vogeser, Monika Brüggemann, Ulrich Sack, Christoph Weinstock, Stefan Zimmermann, Albrecht Stenzinger
{"title":"AWMF Position Statement on the Revision of the EU's New Legislative Framework regarding the accreditation of medical laboratories.","authors":"Michael Vogeser, Monika Brüggemann, Ulrich Sack, Christoph Weinstock, Stefan Zimmermann, Albrecht Stenzinger","doi":"10.1515/cclm-2026-0986","DOIUrl":"https://doi.org/10.1515/cclm-2026-0986","url":null,"abstract":"","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148905146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书